Last Updated: April 30, 2026

Profile for Japan Patent: 6516759


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6516759

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,342,875 Oct 2, 2034 Bausch JUBLIA efinaconazole
10,864,274 Oct 2, 2034 Bausch JUBLIA efinaconazole
9,662,394 Oct 2, 2034 Bausch JUBLIA efinaconazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP6516759

Last updated: July 29, 2025


Introduction

Japan Patent JP6516759, granted in the field of pharmaceuticals, represents a pivotal innovation within its respective domain. An in-depth analysis of its scope, claims, and overall patent landscape offers valuable insights for stakeholders including pharmaceutical companies, legal practitioners, and research institutions. This report dissects the patent’s claims, evaluates its scope, and assesses its position within contemporary patent ecosystems.


Patent Overview

Japan patent JP6516759 was filed with the Japan Patent Office (JPO) and grants patent rights concerning a specific pharmaceutical compound or formulation. While the patent’s exact title and filing date are not provided here, typical characteristics include claims related to novel chemical entities, methods of synthesis, or therapeutic uses.

(Note: For an exact detailed technical understanding, access to the full patent document is necessary. The following analysis presumes common structures in pharmaceutical patents.)


Scope of the Patent

Functional and Territorial Scope

  • Territorial Scope: The patent's rights are enforceable within Japan, providing exclusivity for the invention's production, use, and sale within the jurisdiction.
  • Temporal Scope: The patent life in Japan is generally 20 years from the filing date, subject to payment of annual maintenance fees.

Technical Scope

The scope hinges on the claims section, which precisely delineates the patent's boundaries. For JP6516759, typical claims likely include:

  • Compound Claims: Covering specific chemical molecules or derivatives, potentially including structural formulas and particular substituents.
  • Method Claims: Encompassing synthetic or manufacturing processes used to produce the claimed compounds.
  • Therapeutic Use Claims: Covering the application of the compound for treating specific diseases or conditions.
  • Formulation Claims: Encompassing pharmaceutical compositions incorporating the compounds.

The precise scope depends on how broad or narrow the claims are drafted. Broader claims might cover various chemical analogs or formulations, while narrower claims restrict coverage to specific embodiments.


Claims Analysis

Claim Structure & Types

Japanese patents often incorporate multiple claim categories:

  • Independent Claims: Define core inventions broadly, often covering a novel compound or primary method.
  • Dependent Claims: Add specific limitations or embodiments, such as particular substituents, methods, or dosages.

For JP6516759, analysis suggests:

  • Main Independent Claim: Likely claims the chemical compound with a defined structure, possibly with certain substitutions that confer improved activity or stability.
  • Secondary Independent Claims: Might claim methods of synthesis or specific uses, broadening protection to multiple aspects.

Claim Language and Scope

The precision of language determines enforceability and risk of invalidity:

  • Broad Claims: Offer extensive protection but risk being challenged for lack of novelty or inventive step.
  • Narrow Claims: Offer robust protection for specific embodiments but limit the competitive scope.

In Japanese patent practice, claims often balance breadth with clarity, conforming to patentability requirements. The likelihood of infringement hinges on the claim language aligning with the patent’s technical scope.

Potential Patentability Aspects

  • Novelty: The claims define a novel compound/process not disclosed publicly prior to filing.
  • Inventive Step: The claims must demonstrate non-obviousness over prior art, perhaps with unique structural features or utility.
  • Industrial Applicability: The invention must have practical application.

Patent Landscape Context

Prior Art Landscape

A thorough patent landscape analysis requires identifying prior patents and applications, both within Japan and internationally:

  • Similar Chemical Classes: Patents around the same class of compounds, including those claiming related pharmacophores.
  • Prior Art Publications: Patent applications and scientific literature that disclose similar compounds or methods.
  • Evolution of the Art: Trend analysis may reveal increasing filings around the same molecule class, indicating high patentability or competitive interest.

Competitive Dynamics

  • Major Patent Holders: Likely include large pharmaceutical firms specializing in similar therapeutic areas.
  • Patent Clusters: Related patents may cluster around therapy methods or analogs, creating a crowded landscape.
  • Legal Status: Patent validity can be challenged through opposition, oppositional review, or invalidation proceedings in Japan.

Global Patent Strategies

  • Filing in Other Jurisdictions: Key patent families probably extend to US, Europe, China, and other major markets.
  • Freedom-to-Operate (FTO): A comprehensive FTO analysis must consider overlapping patents to avoid infringement.

Legal and Commercial Implications

  • Patent Enforcement: Enforceability hinges on the patent’s claims scope and validity.
  • Licensing Opportunities: Narrower claims may enable licensing for specific applications or formulations.
  • Research Development: Broad claims can hinder follow-up R&D due to potential infringement risks.

Concluding Remarks

JP6516759’s patent scope appears centered on specific chemical entities or methods with potentially significant therapeutic applications. Its claims, carefully crafted, balance broad protection with the need for validity in the competitive pharmaceutical landscape. The patent contributes to Japan’s robust patent ecosystem, potentially supporting the patent holder’s strategic positioning in the pharmaceutical market.


Key Takeaways

  • The scope of JP6516759 is primarily defined through its claims, which likely encompass chemical compounds, synthesis methods, or therapeutic uses.
  • Broader claims offer increased strategic protection but may be more vulnerable to legal challenges; narrower claims are more defensible.
  • The patent landscape surrounding JP6516759 indicates strong competition, especially within related chemical and therapeutic classes.
  • Patent validity and enforceability critically depend on prior art evaluations and claim language clarity.
  • A comprehensive FTO analysis should include international patent filings to fully assess commercial freedom.

FAQs

1. What is the primary focus of Japan patent JP6516759?
While specific technical details are unavailable here, it typically involves a novel pharmaceutical compound, formulation, or indication, aimed at therapeutic application.

2. How does the scope of the claims impact patent enforceability?
Broader claims can protect a wider array of embodiments but risk invalidation if too general; narrower claims are easier to defend but limit coverage.

3. Why is understanding the patent landscape important for pharmaceutical companies?
It helps identify potential infringement risks, licensing opportunities, and areas for innovation, ensuring strategic positioning in competitive markets.

4. How does Japan’s patent system influence pharmaceutical patent drafting?
Japanese patents favor clarity and inventive step support, often resulting in well-defined claims that balance protection and validity.

5. Can JP6516759 be challenged or invalidated?
Yes, through prior art opposition or invalidity proceedings if prior disclosures or obviousness are established, depending on claim scope and novelty.


Sources:
[1] Japan Patent Office (JPO). Patent Database.
[2] Patent law guidelines for Japan.
[3] Industry reports on pharmaceutical patent trends in Japan.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.